Rectal cancer involves one-third of colorectal cancers (CRCs). Recently, data supported that DNA methylation have a role in CRC pathogenesis. In the present study we aimed to analyze the methylation status of MGMT and ERCC1 promoter regions in blood and tissue of patients with benign and malignant rectal tumors. We also studied the methylated MGMT and ERCC1 genes and their relations with clinicopathological features. Furthermore, we suggested that methylation may play a critical function in the regulation of MGMT and ERCC1 expression. Fifty patients with non-metastatic cancer rectum and 43 patients with benign rectal lesions were involved in the study. DNA extraction from blood and rectal specimens was done to analyze the methylation status of MGMT and ERCC1 genes by methylation-specific PCR method. RNA was extracted also to determine the expression levels of these genes by real time-PCR. The frequency of MGMT and ERCC1 methylation was significantly higher in rectum cancers than in benign tumors both for the tissue and the blood (p < 0.001). There was no relation between MGMT or ERCC1 methylation and clinicopathological features; while they were correlated with the response to therapy. An interesting finding that the agreement of the methylation levels in the blood and rectal tissue was classified as good kappa = 0.78) for MGMT gene and as very good (kappa = 0.85) for ERCC1. Lastly, the MGMT and ERCC1 genes methylation was associated with down-regulation of their mRNA expression when compared with the non-methylated status. Our findings provided evidence that both blood and tumor tissue MGMT and ERCC1 methylation were associated with cancer rectum. MGMT or ERCC1 methylation in blood could be suitable non-invasive biomarkers differentiating benign and malignant rectal tumors. Furthermore, the methylation of the MGMT and ERCC1 promoter regions was associated with down-regulation of their mRNA expression.
机构:
Department of Oncology,The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University
Jian Wang
Xi-Qiao Zhou
论文数: 0引用数: 0
h-index: 0
机构:
Department of Gastroenterology,The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University
Xi-Qiao Zhou
Jing-Ying Li
论文数: 0引用数: 0
h-index: 0
机构:
Department of Oncology,The Second Affiliated Hospital of Nanchang UniversityDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University
Jing-Ying Li
Jian-Feng Cheng
论文数: 0引用数: 0
h-index: 0
机构:
Gastroenterology,Department of Internal Medicine,Carolinas Medical Center,University of North Carolina Charlotte Campus,1000Blythe Blvd,Charlotte,NC 28203,USADepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University
Jian-Feng Cheng
Xiao-Ning Zeng
论文数: 0引用数: 0
h-index: 0
机构:
Department of Respiratory Medicine,The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University
Xiao-Ning Zeng
Xiao Li
论文数: 0引用数: 0
h-index: 0
机构:
Department of Pathology,The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University
Xiao Li
Ping Liu
论文数: 0引用数: 0
h-index: 0
机构:
Department of Oncology,The First Affiliated Hospital of Nanjing Medical UniversityDepartment of Oncology,The First Affiliated Hospital of Nanjing Medical University